Search research articles
Contact Us
Filters
Showing results (481-490 of 519) with videos related to
Page
of 52
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
February 18, 2009
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept
Y Ioannou, Z Romay-Penabad, C Pericleous, et al.
Lupus
|
December 21, 2013
The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease
M A Khamashta, I N Bruce, C Gordon, et al.
European Journal of Immunology
|
March 4, 1998
Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis
C T Ravirajan, M A Rahman, L Papadaki, et al.
Molecular Immunology
|
March 1, 1996
Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA
J K Kalsi, A C Martin, Y Hirabayashi, et al.
Arthritis and Rheumatism
|
February 1, 1989
Comment on the article by Tomana et al
J S Axford, K Bodman, F C Hay, et al.
Lupus
|
November 1, 1991
Sequence analysis and idiotypic relationships of BEG-2, a human fetal antibody reactive with DNA
R A Watts, J L Hillson, I R Oppliger, et al.
Journal of Immunological Methods
|
July 20, 1990
Analysis of glycosylation changes in IgG using lectins
N Sumar, K B Bodman, T W Rademacher, et al.
European Journal of Immunology
|
November 9, 2000
Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block
P Eftekhari, L Sallé, F Lezoualc'h, et al.
British Journal of Rheumatology
|
August 1, 1993
Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus
L S Teh, M K Lee, F Wang, et al.
The Journal of Rheumatology
|
November 11, 1999
The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis
E H Choy, E C Rankin, D Kassimos, et al.
Page
of 52
Search research articles
Search
Showing results (481-490 of 519) with videos related to
Sort By:
Page
of 52
Journal of Thrombosis and Haemostasis : JTH
|
February 18, 2009
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept
Y Ioannou, Z Romay-Penabad, C Pericleous, et al.
Lupus
|
December 21, 2013
The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease
M A Khamashta, I N Bruce, C Gordon, et al.
European Journal of Immunology
|
March 4, 1998
Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis
C T Ravirajan, M A Rahman, L Papadaki, et al.
Molecular Immunology
|
March 1, 1996
Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA
J K Kalsi, A C Martin, Y Hirabayashi, et al.
Arthritis and Rheumatism
|
February 1, 1989
Comment on the article by Tomana et al
J S Axford, K Bodman, F C Hay, et al.
Lupus
|
November 1, 1991
Sequence analysis and idiotypic relationships of BEG-2, a human fetal antibody reactive with DNA
R A Watts, J L Hillson, I R Oppliger, et al.
Journal of Immunological Methods
|
July 20, 1990
Analysis of glycosylation changes in IgG using lectins
N Sumar, K B Bodman, T W Rademacher, et al.
European Journal of Immunology
|
November 9, 2000
Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block
P Eftekhari, L Sallé, F Lezoualc'h, et al.
British Journal of Rheumatology
|
August 1, 1993
Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus
L S Teh, M K Lee, F Wang, et al.
The Journal of Rheumatology
|
November 11, 1999
The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis
E H Choy, E C Rankin, D Kassimos, et al.
Page
of 52